A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors

Name: A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors
License: Public Domain

Cogent Biosciences, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

intrahepatic cholangiocarcinoma (icc), cholangiocarcinoma, other solid tumors, adult, fgfr2 gene fusion/rearrangement, fgfr2 gene amplification, fgfr2 gene short variants

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 454126
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.